NASDAQ:AMRI
Delisted

Albany Molecular Research Fund Forecast

$21.74
+0 (+0%)
At Close: Jan 16, 2018
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Albany Molecular Research Fund and on which exchange is it traded?
The symbol for Albany Molecular Research is AMRI and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Albany Molecular Research Fund?
Albany Molecular Research holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Albany Molecular Research Fund?
Albany Molecular Research Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Albany Molecular Research Fund.

What's the current price of Albany Molecular Research Fund?
As of the end of day on the 2018-01-16, the price of an Albany Molecular Research (AMRI) share was $21.74.

What is the 52-week high and low for Albany Molecular Research Fund?
The 52-week high for Albany Molecular Research Fund is $22.17 and the 52-week low is $13.01.
Click to get the best stock tips daily for free!

About Albany Molecular Research

Albany Molecular Research, Inc., a contract research and manufacturing company, provides integrated drug discovery, development, and manufacturing services primarily in the United States, Europe, and Asia. The company’s Discovery and Development Services segment offers services from target identification tools to investigational new drug enabling activities, such as diverse chemistry library design and synthesis, high throughput and high content... AMRI Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT